Astrazeneca AZN
NYSE AZN
$160.15 +0.51 (+0.32%)
As of: Sep 11, 2026 · 3:59 PM EDT

Astrazeneca (AZN) Net Cash Flow Growth (3y) (2012 - 2026)

Analysis

Astrazeneca (AZN) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Asml Holding 659.69 Bn 643.71 Bn 5.90 Bn -
2 General Electric 337.12 Bn 327.78 Bn 6.95 Bn -31.69%
3 Astrazeneca 247.89 Bn 242.60 Bn 12.86 Bn -26.81%
4 Citigroup 236.49 Bn -2,065.81 Bn 24.75 Bn -
5 Bhp 220.99 Bn 202.45 Bn - -
6 Rio Tinto 206.31 Bn 201.93 Bn - -
7 Diageo 192.64 Bn 190.61 Bn - -
8 National Grid 165.59 Bn 161.82 Bn - -
9 Unilever 135.28 Bn 128.25 Bn - -
10 Hdfc Bank 119.43 Bn 82.28 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -26.81%
Mar 31, 2026 -6.01%
Dec 31, 2025 -47.11%
Jun 30, 2025 41.82%
Mar 31, 2025 -7.06%
Dec 31, 2024 38.86%
Sep 30, 2024 30.33%
Jun 30, 2024 -31.27%
Mar 31, 2024 -69.16%
Dec 31, 2023 49.52%
Jun 30, 2023 0.28%
Mar 31, 2023 133.62%
Dec 31, 2022 292.67%
Jun 30, 2022 5.59%
Mar 31, 2022 277.82%
Dec 31, 2021 -87.60%
Sep 30, 2021 -206.03%
Jun 30, 2021 185.05%
Mar 31, 2021 165.50%
Dec 31, 2020 42.73%